1
Xu J#, Gong H, Tong R, Liu M, Cui X*. Finger-In-Glove Sign in Congenital Bronchial Atresia. Respirol Case Rep. 2025 Jun 18;13(6):e70247. doi: 10.1002/rcr2.70247. PMID: 40535724.
2
Li H#, Li Z#, Cui X, Liu X, Zhao J, Zhang Y, Wang C, Li B, Fan Y, Han J, Xia Y, Xiong Z, Zou X, Zhu Y, Li M, Lu B*, Cao B*. Mycobacterium tuberculosis Detection in Diverse Clinical Specimens by GeneXpert MTB/RIF: A Large-Scale Retrospective Study. Infect Drug Resist. 2025 May 8;18:2401-2413. doi: 10.2147/IDR.S514220. PMID: 40357422.
3
Zheng Y#, He D#, Zuo W#, Wang W#, Wu K, Wu H, Yuan Y, Huang Y, Li H, Lu Y, Zhao L, Wang X, Wang J, Zhang Y, Zou G, Li H*, Wang Z*, Cao B*. Influenza A virus dissemination and infection leads to tissue resident cell injury and dysfunction in viral sepsis. EBioMedicine. 2025 Jun;116:105738. doi: 10.1016/j.ebiom.2025.105738. Epub 2025 May 13. PMID: 40367638.
4
Feilong Z#, Wenting Y, Binghuai L*, Bin C*. Dynamic global variation in resistance and hypervirulence of carbapenem-resistant Klebsiella pneumoniae between 2010 and 2023. J Infect. 2025 Jun;90(6):106493. doi: 10.1016/j.jinf.2025.106493. Epub 2025 Apr 24. PMID: 40286916.
5
Zhang Y, Li Z, Shi H, Lei Z, Pu D, Liu Q, Zhang F, Zhao J, Liu X, Lu B, Cao B. High-level ceftazidime-avibactam resistance by in-host evolution of blaKPC genes: Emergence of a novel blaKPC-102 variant and increase of blaKPC-33 copy number in Klebsiella pneumoniae strains from a lung transplantation recipient. Int J Antimicrob Agents. 2025 Aug;66(2):107521. doi: 10.1016/j.ijantimicag.2025.107521. Epub 2025 Apr 21. PMID: 40268257.
6
Monto AS, Kuhlbusch K, Bernasconi C, Cao B, Cohen HA, Graham E, Hurt AC, Katugampola L, Kamezawa T, Lauring AS, McLean B, Takazono T, Widmer A, Wildum S, Cowling BJ. Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza. N Engl J Med. 2025 Apr 24;392(16):1582-1593. doi: 10.1056/NEJMoa2413156. PMID: 40267424.
7
Zhang H#, Yang P#, Gu X#, Sun Y#, Zhang R#, Zhang D#, Zhang J, Wang Y, Ma C, Liu M, Ma J, Li A, Wang Y, Ma X, Cui X, Wang Y, Liu Z, Wang W, Zheng Z, Li Y, Wu J, Wang Q*, Cao B*. Health outcomes one year after Omicron infection among 12,789 adults: a community-based cross-sectional study. Lancet Reg Health West Pac. 2025 Mar 13;56:101507. doi: 10.1016/j.lanwpc.2025.101507. PMID: 40226780.
8
Li H#, Liu H#, Wu H#, Guo C#, Zuo W, Zheng Y, Deng X, Xu J, Wang Y, Wang Z, Lu B, Hou B*, Cao B*. Reading of human acute immune dynamics in omicron SARS-CoV-2 breakthrough infection. Emerg Microbes Infect. 2025 Dec;14(1):2494705. doi: 10.1080/22221751.2025.2494705. Epub 2025 May 6. PMID: 40231451.
9
Wei C#, Xu Y#, Zheng Y#, Hong L, Lyu C, Li H*, Cao B*. The LTB4-BLT1 axis attenuates influenza-induced lung inflammation by suppressing NLRP3 activation. Cell Death Discov. 2025 Apr 6;11(1):148. doi: 10.1038/s41420-025-02450-8. PMID: 40189592;
10
Zhang Y, Pu D, Liu Q, Li B, Lu B, Cao B. Epidemic Outbreak of Respiratory Syncytial Virus Infection After the end of the Zero-COVID-19 Policy in China: Molecular Characterization and Disease Severity Associated With a Novel RSV-B Clade. J Med Virol. 2025 Apr;97(4):e70343. doi: 10.1002/jmv.70343. PMID: 40207902.
11
Ma T, Wang Y, Huang C, Zhang X, An Y, Zhang Q, Kong Q, Cao B. Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge. Arch Microbiol. 2025 Mar 28;207(5):103. doi: 10.1007/s00203-025-04306-2. PMID: 40152989.
12
Cao W#, Su W#, Song X#, Ma L#, Li Y#, Yan H, Li J, Yang J, Zhao J, Liu K, Qiu R, He G, Shi F, Wang J, Suo L, Liu X, Zhang Y, Li L, Zhao H, Li T, Yi G, Huang Z, Gao S, Wang Y*, Cao B*. Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Infect Dis. 2025 Mar 25:jiaf075. doi: 10.1093/infdis/jiaf075. Epub ahead of print. PMID: 40131019.
13
Zhang R#, Yu J, Shang X, Wang Z, Li H*, Cao B*. Heterogeneity in clinical patterns of adult lung abscess patients: an 8-year retrospective study in a tertiary hospital. BMC Pulm Med. 2025 Mar 5;25(1):101. doi: 10.1186/s12890-025-03487-2. PMID: 40045326;
14
Yan Y#, Shang L#, Xu J, Gu X, Fan G, Wang Y, Cao B*. The prevalence and outcomes of viremia in patients with acute respiratory viral infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2025 Jan 28:S1198-743X(25)00035-7. doi: 10.1016/j.cmi.2025.01.027. Epub ahead of print. PMID: 39884502.
15
Yan M#, Shang L#, Wang Y#, Wang C, Cao B*. Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis. Int J Antimicrob Agents. 2025 Jan 4;65(3):107440. doi: 10.1016/j.ijantimicag.2024.107440. Epub ahead of print. PMID: 39761759.
16
Zhuo X#, Lei Z, Pu D, Wu Y, Zhao J*, Cao B*. Hypervirulent Klebsiella pneumoniae have better clinical outcomes than classical Klebsiella pneumoniae for lower respiratory tract infection patients. BMC Microbiol. 2025 Jan 22;25(1):40. doi: 10.1186/s12866-024-03726-2. PMID: 39844054; PMCID: PMC11753108.
